Article
Rapamycin improves the quality and developmental competence of in vitro matured oocytes in aged mice and humans
26 Nov 2022
Abstract excerpt
Women over age 35 suffer from the inadequate number and poor quality of oocytes during assisted reproductive treatment, and making full use of the oocytes by in vitro maturation (IVM) is crucial. Rapamycin could improve the developmental competences of the post-maturation oocytes during in vitro aging, yet its effects on the IVM process of oocytes from an aged population were not clear. In this study, the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
